lomerizine has been researched along with Disease Models, Animal in 10 studies
lomerizine: used to treat migraines
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Following partial optic nerve transection, hyper-phosphorylation of Tau and acetylated tubulin immunoreactivity were increased, and Nogo-A immunoreactivity was decreased, indicating that axonal changes occurred acutely." | 1.46 | Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma. ( Bartlett, CA; Chiha, W; Fitzgerald, M; Giacci, MK; Harvey, AR; Hodgetts, SI; O'Hare Doig, RL; Smith, NM; Yates, NJ, 2017) |
| "Partial optic nerve transection is an excellent model in which to unequivocally differentiate events occurring during secondary degeneration from those resulting from primary CNS injury." | 1.35 | Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine. ( Bartlett, CA; Dunlop, SA; Evill, L; Fitzgerald, M; Harvey, AR; Rodger, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zamponi, GW | 1 |
| Feng, ZP | 1 |
| Zhang, L | 1 |
| Pajouhesh, H | 2 |
| Ding, Y | 1 |
| Belardetti, F | 1 |
| Dolphin, D | 1 |
| Mitscher, LA | 1 |
| Snutch, TP | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| O'Hare Doig, RL | 2 |
| Chiha, W | 1 |
| Giacci, MK | 1 |
| Yates, NJ | 1 |
| Bartlett, CA | 4 |
| Smith, NM | 2 |
| Hodgetts, SI | 1 |
| Harvey, AR | 2 |
| Fitzgerald, M | 4 |
| Toomey, LM | 1 |
| Majimbi, M | 1 |
| Gopalasingam, G | 1 |
| Rodger, J | 2 |
| Savigni, DL | 1 |
| Szymanski, CR | 1 |
| Lozić, I | 1 |
| Evill, L | 1 |
| Dunlop, SA | 1 |
| Ito, Y | 1 |
| Nakamura, S | 1 |
| Tanaka, H | 1 |
| Tsuruma, K | 1 |
| Shimazawa, M | 1 |
| Araie, M | 2 |
| Hara, H | 1 |
| Mayama, C | 1 |
| Ishii, K | 1 |
| Ota, T | 1 |
| Tomidokoro, A | 1 |
| Handa, J | 1 |
| Shiino, A | 2 |
| Kidooka, M | 1 |
1 review available for lomerizine and Disease Models, Animal
| Article | Year |
|---|---|
[Ca antagonists in neurosurgical practice].
Topics: Animals; Anticonvulsants; Brain; Calcium Channel Blockers; Cerebral Infarction; Disease Models, Anim | 1990 |
9 other studies available for lomerizine and Disease Models, Animal
| Article | Year |
|---|---|
Scaffold-based design and synthesis of potent N-type calcium channel blockers.
Topics: Analgesics; Animals; Binding Sites; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Chan | 2009 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Female; Imidazoles; Mac | 2017 |
Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection.
Topics: Animals; Calcium Channel Blockers; Calcium-Binding Proteins; Cell Adhesion Molecules, Neuronal; Dise | 2019 |
Three Ca2+ channel inhibitors in combination limit chronic secondary degeneration following neurotrauma.
Topics: Adenosine Triphosphate; Animals; Basic Helix-Loop-Helix Transcription Factors; Calcium Channel Block | 2013 |
Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine.
Topics: Animals; Axons; Calcium Channel Blockers; Calcium Channels, L-Type; Disease Models, Animal; Female; | 2009 |
Lomerizine, a Ca2+ channel blocker, protects against neuronal degeneration within the visual center of the brain after retinal damage in mice.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Geniculate Bodies; Male; Mice; Mice, Inbr | 2010 |
Changes in optic nerve head circulation in response to vasoactive agents: intereye comparison in monkeys with experimental unilateral glaucoma.
Topics: Animals; Arginine; Blood Circulation; Blood Flow Velocity; Calcium Channel Blockers; Disease Models, | 2012 |
[Experimental studies on pharmacologic protection of the brain against focal ischemia. 2. Effects of KB-2796 and nicardipine on focal brain ischemia in rats].
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Disease Models, Anim | 1989 |